SUMMARY One hundred cases oftransitional cell carcinoma ofthe bladder were studied to determine whether squamous metaplasia and other histological features within the bladder can be of value in predicting outcome of treatment with radiotherapy. Sixty cases showed the changes of squamous metaplasia, and of this group 46 (78%) failed to respond to radiotherapy. A significant response rate of 90% was seen in the 40 tumours without squamous metaplasia.
The heterogeneity of invasive bladder carcinoma has prompted many studies of histological features in an attempt to relate these to prognosis.`13 Most studies have been performed on radical cystectomy specimens, and there is little information about the histological features in transurethral resection material which may be relevant to the prognosis of patients, especially those treated with radiotherapy.
The presence of squamous metaplasia is well recognised in transitional cell carcinoma of the bladder,45 but its importance for prognosis is not known. It has been shown that squamous cell carcinoma of the bladder is more resistant to radiotherapy than its transitional cell counterpart,67 and this aroused our interest in the responsiveness to radiotherapy of transitional cell carcinomas showing squamous metaplasia.
It has been suggested that if radioresponsiveness of the tumour could be predicted more accurately before irradiation then non-responders could be offered alternative treatment including early cystectomy. We therefore undertook a study to determine whether the histological features of invasive transitional cell carcinoma of the bladder were related to or could be used to predict the response of the tumour to radiotherapy.
Material and methods
From the records of the departments of urology and histopathology at this hospital 111 patients with muscle invasive transitional cell carcinoma of the bladder were identified (International Union Against Cancer (UICC) and American (Jewett) classification Accepted for publication 6 October 1988 stage T2/T3).' These patients presented between 1980 and 1985 and had received radiotherapy. Six cases with invasion of the prostate (UICC stage 4) were excluded as this group is recognised as having a poor prognosis and as being resistant to radiotherapy.8 In five cases the original pathology material was unavailable, thus leaving 100 cases. The mean age of patients was 68 3 years, range 33-85. There were 78 men and 22 women.
The histological sections were processed from tissue fixed in 10% formol saline by standard techniques and stained with haematoxylin and eosin. The original tumours before treatment had been reviewed independently by three pathologists (JM, RZ, SB) unaware of the clinical outcome. Between one and seven blocks of tissue were available in each case (mean 2.6).
The sections were assessed for grade using the WHO classification,5 degree and type of inflammatory cell infiltrate, the presence of necrosis, the presence of carcinoma in situ adjacent to the tumour, papillary or solid growth pattern, vascular invasion and the presence of squamous metaplasia within the tumour.5 Squamous metaplasia was diagnosed using the usual criteria including abundant eosinophilic cytoplasm, large oval nuclei with an open chromatin pattern and prominent nucleoli. Cellular alignment, intercellular bridges, and keratin production were also useful features. The extent of squamous metaplasia was classified in three groups. Tumours were therefore graded 0 (no squamous metaplasia), 1-3 (small, moderate, or extensive areas of squamous metaplasia) initially, and then simply + (0)/-(1-3) for further statistical analysis.
The results were correlated with the response to radiotherapy, asjudged on subsequent cystoscopy and Positive  13  47  60  36  24  33  27  35  25  26  34   metaplasia  Negative   36  4  40  19  21  20  20  14  26  19  21   Field change  Positive  26  29  36  19  55  30  25  29  26  25  30  Negative   23  22  24  21  45  23  22  20  25  20  25  Necrosis  Positive  25  28  33  20  30  23  53  23  30  17  36   Negative  24  23  27  20  25  22  47  26  21  28  19  Vessel  Positive  22  27  35  14  29  20  23  26  49  21  28   invasion  Negative  27  24  25  26  26  25  30  21  51  24  27  Growth  P  22  23  26  19  25  20   17   28  21  24  45  pattern  S  27  28  34  21  30  25  36  19  28  27 Lack ofresponse to radiotherapy in transitional cell bladder carcinomas showing squamous metaplasia 253 recognised that transitional cell carcinoma with squamous areas is an entity distinct from squamous cell carcinoma. 45 Our findings indicate that the presence of squamous metaplasia within a tumour is associated with a poor response to radiotherapy. This agrees with the work of Tannenbaum et al. Other methods of treatment, including chemotherapy and partial and total cystectomy, may give better results in this group than those currently in use.
It was considered important to try to exclude the possibility that the squamous metaplasia in transitional cell carcinoma was a reaction to necrosis or inflammation. Squamous metaplasia affecting nonneoplastic epithelium is commonly seen in the bladder in response to calculi or chronic inflammation. The prostate may also show this change around areas of infarction and inflammation. Our results showed no correlation between the presence of squamous metaplasia and these other histological features, and we therefore conclude that squamous metaplasia marks a specific phenotypic variant of transitional cell carcinoma.
Our results show no evidence that tumours with a papillary surface respond better to radiotherapy. This finding does not support those of Slack and Prout or Shipley et al, but is in agreement with the findings of Boileau et al. We attempted to exclude the possibility that papillary growth was associated with more superficial growth and invasion, as suggested by Soto et al,"4 as well as by Slack and Prout, by ensuring that all patients had histologically confirmed T2/T3 tumours.
We also found no correlation between small vessel invasion and the response to radiotherapy, with a similar percentage of tumours showing this feature to those reported in other studies.'"'7 The lack ofassociation between vessel invasion and response to radiotherapy is supported by the study of Pomerance on blood vessel invasion and prognosis.
In conclusion, we found that the presence of squamous metaplasia within invasive transitional cell carcinoma of the bladder is associated with failure of response to radiotherapy in 78% of cases, and that absence of this change is associated with a 90% complete response. The presence of squamous metaplasia in these tumours is not related to the presence of inflammation or necrosis but may be an expression of tumour phenotype. We suggest that histopathologists and urologists should place greater emphasis on the reporting of squamous metaplasia within transitional cell tumours. If our findings are confirmed in further studies radiotherapy may be shown to be inappropriate treatment for patients with transitional cell carcinoma showing this feature.
